BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alves A, Adam R, Majno P, Delvart V, Azoulay D, Castaing D, Bismuth H. Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol. 2003;10:705-710. [PMID: 12839857 DOI: 10.1245/aso.2003.07.024] [Cited by in Crossref: 84] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Langan RC, Ripley RT, Davis JL, Prieto PA, Datrice N, Steinberg SM, Bratslavsky G, Rudloff U, Kammula US, Stojadinovic A. Liver directed therapy for renal cell carcinoma. J Cancer. 2012;3:184-190. [PMID: 22558019 DOI: 10.7150/jca.4456] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
2 Kim SH, Kim JK, Park EY, Joo J, Lee KH, Seo HK, Joung JY, Chung J. Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy. PLoS One 2019;14:e0211105. [PMID: 30785902 DOI: 10.1371/journal.pone.0211105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Hamada S, Ito K, Kuroda K, Sato A, Asakuma J, Horiguchi A, Seguchi K, Asano T. Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis. Mol Clin Oncol 2015;3:63-8. [PMID: 25469271 DOI: 10.3892/mco.2014.432] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
4 Chatzizacharias NA, Rosich-Medina A, Dajani K, Harper S, Huguet E, Liau SS, Praseedom RK, Jah A. Surgical management of hepato-pancreatic metastasis from renal cell carcinoma. World J Gastrointest Oncol 2017; 9(2): 70-77 [PMID: 28255428 DOI: 10.4251/wjgo.v9.i2.70] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
5 Kramer MW, Merseburger AS, Peters I, Waalkes S, Kuczyk MA. [Systemic and surgical management of metastatic renal cell carcinoma]. Urologe A 2012;51:217-25. [PMID: 22009257 DOI: 10.1007/s00120-011-2713-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Kim SH, Park WS, Park B, Pak S, Chung J. A Retrospective Analysis of the Impact of Metastasectomy on Prognostic Survival According to Metastatic Organs in Patients With Metastatic Renal Cell Carcinoma. Front Oncol. 2019;9:413. [PMID: 31179242 DOI: 10.3389/fonc.2019.00413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Beetz O, Söffker R, Cammann S, Oldhafer F, Vondran FWR, Imkamp F, Klempnauer J, Kleine M. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades. Langenbecks Arch Surg 2020;405:97-106. [PMID: 31938833 DOI: 10.1007/s00423-019-01852-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Qasrawi R, Silve L, Burdío F, Abdeen Z, Ivorra A. Anatomically Realistic Simulations of Liver Ablation by Irreversible Electroporation: Impact of Blood Vessels on Ablation Volumes and Undertreatment. Technol Cancer Res Treat 2017;16:783-92. [PMID: 28093955 DOI: 10.1177/1533034616687477] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
9 Kurosch M, Buse S, Bedke J, Wagener N, Haferkamp A, Hohenfellner M. [Palliative and supportive therapy in cases of renal cell carcinoma]. Urologe A 2007;46:40-4. [PMID: 17186190 DOI: 10.1007/s00120-006-1268-3] [Reference Citation Analysis]
10 Bex A. Integrating metastasectomy and stereotaxic radiosurgery in the treatment of metastatic renal cell carcinoma. EJC Supplements. 2013;2:192-203. [PMID: 26217128 DOI: 10.1016/j.ejcsup.2013.07.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Deutsch GB, Flaherty DC, Kirchoff DD, Bailey M, Vitug S, Foshag LJ, Faries MB, Bilchik AJ. Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic Therapy. JAMA Surg 2017;152:672-8. [PMID: 28384791 DOI: 10.1001/jamasurg.2017.0459] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 7.2] [Reference Citation Analysis]
12 Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, Stief CG, Jauch KW, Bruns CJ. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol. 2010;28:543-547. [PMID: 20440505 DOI: 10.1007/s00345-010-0560-4] [Cited by in Crossref: 92] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
13 Kuei A, Saab S, Cho SK, Kee ST, Lee EW. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol 2015; 21(27): 8271-8283 [PMID: 26217079 DOI: 10.3748/wjg.v21.i27.8271] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
14 Staehler M, Haseke N, Schöppler G, Stadler T, Adam C, Stief CG. [Therapy strategies for advanced renal cell carcinoma]. Urologe A 2006;45:99-110, quiz 111-2. [PMID: 16372186 DOI: 10.1007/s00120-005-0982-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
15 Gill DM, Agarwal N, Vaishampayan U. Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma. Am Soc Clin Oncol Educ Book 2017;37:319-29. [PMID: 28561652 DOI: 10.1200/EDBK_174469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
16 Brehmer B, Piper C, Pfister D, Porres D, Heidenreich A. [Metastasectomy for renal cell cancer]. Urologe A 2012;51:1202-8. [PMID: 22733397 DOI: 10.1007/s00120-012-2872-z] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
17 Fitzgerald TL, Brinkley J, Banks S, Vohra N, Englert ZP, Zervos EE. The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg. 2014;399:989-1000. [PMID: 25148767 DOI: 10.1007/s00423-014-1241-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
18 Nagaraja H, Srivatsa N, Hemalatha S, Shweta S, Raghunath SK. Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma. Indian J Surg Oncol 2018;9:105-9. [PMID: 29563747 DOI: 10.1007/s13193-018-0722-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Neri F, Ercolani G, Di Gioia P, Del Gaudio M, Pinna AD. Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. Updates Surg 2015;67:223-33. [PMID: 26341625 DOI: 10.1007/s13304-015-0315-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
20 Berghen C, Joniau S, Vulsteke C, Albersen M, Devos G, Rans K, Haustermans K, De Meerleer G. Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news. Ecancermedicalscience 2020;14:1036. [PMID: 32565889 DOI: 10.3332/ecancer.2020.1036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Thomas AA, Rini BI, Campbell SC. Integration of surgery and systemic therapy in the management of metastatic renal cancer. Curr Urol Rep 2009;10:35-41. [PMID: 19116094 DOI: 10.1007/s11934-009-0008-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
22 Thelen A, Jonas S, Benckert C, Lopez-Hänninen E, Rudolph B, Neumann U, Neuhaus P. Liver resection for metastases from renal cell carcinoma. World J Surg. 2007;31:802-807. [PMID: 17354021 DOI: 10.1007/s00268-007-0685-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
23 Yoshimatsu M, Shirabe K, Nagao Y, Harada N, Uchiyama H, Yoshizumi T, Taketomi A, Ikeda T, Tatsugami K, Maehara Y. A safe combined nephrectomy and right lobectomy using the liver hanging maneuver for huge renal cell carcinoma directly invading the right lobe of the liver: report of a case. Surg Today 2014;44:1778-82. [PMID: 24048764 DOI: 10.1007/s00595-013-0693-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Heidenreich A, Wilop S, Pinkawa M, Porres D, Pfister D. Surgical resection of urological tumor metastases following medical treatment. Dtsch Arztebl Int 2012;109:631-7. [PMID: 23093995 DOI: 10.3238/arztebl.2012.0631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
25 Kulik U, Lehner F, Bektas H, Klempnauer J. Liver Resection for Non-Colorectal Liver Metastases - Standards and Extended Indications. Viszeralmedizin 2015;31:394-8. [PMID: 26889142 DOI: 10.1159/000439419] [Reference Citation Analysis]
26 Kim JK, Kim SH, Song MK, Joo J, Seo SI, Kwak C, Jeong CW, Song C, Hwang EC, Seo IY, Lee H, Hong SH, Park JY, Chung J. Survival and clinical prognostic factors in metastatic non-clear cell renal cell carcinoma treated with targeted therapy: A multi-institutional, retrospective study using the Korean metastatic renal cell carcinoma registry. Cancer Med 2019;8:3401-10. [PMID: 31070307 DOI: 10.1002/cam4.2222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
27 Wiesner C, Haferkamp A. [Metastatic renal cell carcinoma: therapeutic concepts for non-medicinal treatment]. Urologe A 2011;50:853-60. [PMID: 21678107 DOI: 10.1007/s00120-011-2599-2] [Reference Citation Analysis]
28 Mejean A, Correas JM, Escudier B, de Fromont M, Lang H, Long JA, Neuzillet Y, Patard JJ, Piechaud T. [Kidney tumors]. Prog Urol 2007;17:1101-44. [PMID: 18153989 DOI: 10.1016/s1166-7087(07)74782-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
29 Aloia TA, Adam R, Azoulay D, Bismuth H, Castaing D. Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience. HPB (Oxford). 2006;8:100-105. [PMID: 18333255 DOI: 10.1080/13651820500496266] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]